1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Gene Silencing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Transcriptional
        1.2.3 Post-transcriptional
        1.2.4 Meiotic
    1.3 Market by Application
        1.3.1 Global Gene Silencing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Cancer Treatment
        1.3.3 Neurological Diseases Treatment
        1.3.4 Scar Treatment
        1.3.5 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Gene Silencing Market Perspective (2017-2028)
    2.2 Gene Silencing Growth Trends by Region
        2.2.1 Gene Silencing Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Gene Silencing Historic Market Size by Region (2017-2022)
        2.2.3 Gene Silencing Forecasted Market Size by Region (2023-2028)
    2.3 Gene Silencing Market Dynamics
        2.3.1 Gene Silencing Industry Trends
        2.3.2 Gene Silencing Market Drivers
        2.3.3 Gene Silencing Market Challenges
        2.3.4 Gene Silencing Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Gene Silencing Players by Revenue
        3.1.1 Global Top Gene Silencing Players by Revenue (2017-2022)
        3.1.2 Global Gene Silencing Revenue Market Share by Players (2017-2022)
    3.2 Global Gene Silencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Gene Silencing Revenue
    3.4 Global Gene Silencing Market Concentration Ratio
        3.4.1 Global Gene Silencing Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Gene Silencing Revenue in 2021
    3.5 Gene Silencing Key Players Head office and Area Served
    3.6 Key Players Gene Silencing Product Solution and Service
    3.7 Date of Enter into Gene Silencing Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Silencing Breakdown Data by Type
    4.1 Global Gene Silencing Historic Market Size by Type (2017-2022)
    4.2 Global Gene Silencing Forecasted Market Size by Type (2023-2028)
5 Gene Silencing Breakdown Data by Application
    5.1 Global Gene Silencing Historic Market Size by Application (2017-2022)
    5.2 Global Gene Silencing Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Gene Silencing Market Size (2017-2028)
    6.2 North America Gene Silencing Market Size by Type
        6.2.1 North America Gene Silencing Market Size by Type (2017-2022)
        6.2.2 North America Gene Silencing Market Size by Type (2023-2028)
        6.2.3 North America Gene Silencing Market Share by Type (2017-2028)
    6.3 North America Gene Silencing Market Size by Application
        6.3.1 North America Gene Silencing Market Size by Application (2017-2022)
        6.3.2 North America Gene Silencing Market Size by Application (2023-2028)
        6.3.3 North America Gene Silencing Market Share by Application (2017-2028)
    6.4 North America Gene Silencing Market Size by Country
        6.4.1 North America Gene Silencing Market Size by Country (2017-2022)
        6.4.2 North America Gene Silencing Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Gene Silencing Market Size (2017-2028)
    7.2 Europe Gene Silencing Market Size by Type
        7.2.1 Europe Gene Silencing Market Size by Type (2017-2022)
        7.2.2 Europe Gene Silencing Market Size by Type (2023-2028)
        7.2.3 Europe Gene Silencing Market Share by Type (2017-2028)
    7.3 Europe Gene Silencing Market Size by Application
        7.3.1 Europe Gene Silencing Market Size by Application (2017-2022)
        7.3.2 Europe Gene Silencing Market Size by Application (2023-2028)
        7.3.3 Europe Gene Silencing Market Share by Application (2017-2028)
    7.4 Europe Gene Silencing Market Size by Country
        7.4.1 Europe Gene Silencing Market Size by Country (2017-2022)
        7.4.2 Europe Gene Silencing Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Gene Silencing Market Size (2017-2028)
    8.2 Asia-Pacific Gene Silencing Market Size by Type
        8.2.1 Asia-Pacific Gene Silencing Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Gene Silencing Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Gene Silencing Market Share by Type (2017-2028)
    8.3 Asia-Pacific Gene Silencing Market Size by Application
        8.3.1 Asia-Pacific Gene Silencing Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Gene Silencing Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Gene Silencing Market Share by Application (2017-2028)
    8.4 Asia-Pacific Gene Silencing Market Size by Region
        8.4.1 Asia-Pacific Gene Silencing Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Gene Silencing Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Gene Silencing Market Size (2017-2028)
    9.2 Latin America Gene Silencing Market Size by Type
        9.2.1 Latin America Gene Silencing Market Size by Type (2017-2022)
        9.2.2 Latin America Gene Silencing Market Size by Type (2023-2028)
        9.2.3 Latin America Gene Silencing Market Share by Type (2017-2028)
    9.3 Latin America Gene Silencing Market Size by Application
        9.3.1 Latin America Gene Silencing Market Size by Application (2017-2022)
        9.3.2 Latin America Gene Silencing Market Size by Application (2023-2028)
        9.3.3 Latin America Gene Silencing Market Share by Application (2017-2028)
    9.4 Latin America Gene Silencing Market Size by Country
        9.4.1 Latin America Gene Silencing Market Size by Country (2017-2022)
        9.4.2 Latin America Gene Silencing Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Gene Silencing Market Size (2017-2028)
    10.2 Middle East & Africa Gene Silencing Market Size by Type
        10.2.1 Middle East & Africa Gene Silencing Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Gene Silencing Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Gene Silencing Market Share by Type (2017-2028)
    10.3 Middle East & Africa Gene Silencing Market Size by Application
        10.3.1 Middle East & Africa Gene Silencing Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Gene Silencing Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Gene Silencing Market Share by Application (2017-2028)
    10.4 Middle East & Africa Gene Silencing Market Size by Country
        10.4.1 Middle East & Africa Gene Silencing Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Gene Silencing Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Alnylam Pharmaceuticals
        11.1.1 Alnylam Pharmaceuticals Company Details
        11.1.2 Alnylam Pharmaceuticals Business Overview
        11.1.3 Alnylam Pharmaceuticals Gene Silencing Introduction
        11.1.4 Alnylam Pharmaceuticals Revenue in Gene Silencing Business (2017-2022)
        11.1.5 Alnylam Pharmaceuticals Recent Developments
    11.2 Benitec Biopharma
        11.2.1 Benitec Biopharma Company Details
        11.2.2 Benitec Biopharma Business Overview
        11.2.3 Benitec Biopharma Gene Silencing Introduction
        11.2.4 Benitec Biopharma Revenue in Gene Silencing Business (2017-2022)
        11.2.5 Benitec Biopharma Recent Developments
    11.3 Arrowhead Pharmaceuticals
        11.3.1 Arrowhead Pharmaceuticals Company Details
        11.3.2 Arrowhead Pharmaceuticals Business Overview
        11.3.3 Arrowhead Pharmaceuticals Gene Silencing Introduction
        11.3.4 Arrowhead Pharmaceuticals Revenue in Gene Silencing Business (2017-2022)
        11.3.5 Arrowhead Pharmaceuticals Recent Developments
    11.4 Merck Group
        11.4.1 Merck Group Company Details
        11.4.2 Merck Group Business Overview
        11.4.3 Merck Group Gene Silencing Introduction
        11.4.4 Merck Group Revenue in Gene Silencing Business (2017-2022)
        11.4.5 Merck Group Recent Developments
    11.5 Eli Lilly (Dicerna Pharmaceuticals)
        11.5.1 Eli Lilly (Dicerna Pharmaceuticals) Company Details
        11.5.2 Eli Lilly (Dicerna Pharmaceuticals) Business Overview
        11.5.3 Eli Lilly (Dicerna Pharmaceuticals) Gene Silencing Introduction
        11.5.4 Eli Lilly (Dicerna Pharmaceuticals) Revenue in Gene Silencing Business (2017-2022)
        11.5.5 Eli Lilly (Dicerna Pharmaceuticals) Recent Developments
    11.6 Monsanto (Bayer AG)
        11.6.1 Monsanto (Bayer AG) Company Details
        11.6.2 Monsanto (Bayer AG) Business Overview
        11.6.3 Monsanto (Bayer AG) Gene Silencing Introduction
        11.6.4 Monsanto (Bayer AG) Revenue in Gene Silencing Business (2017-2022)
        11.6.5 Monsanto (Bayer AG) Recent Developments
    11.7 RXi Pharmaceuticals
        11.7.1 RXi Pharmaceuticals Company Details
        11.7.2 RXi Pharmaceuticals Business Overview
        11.7.3 RXi Pharmaceuticals Gene Silencing Introduction
        11.7.4 RXi Pharmaceuticals Revenue in Gene Silencing Business (2017-2022)
        11.7.5 RXi Pharmaceuticals Recent Developments
    11.8 Silence Therapeutics plc
        11.8.1 Silence Therapeutics plc Company Details
        11.8.2 Silence Therapeutics plc Business Overview
        11.8.3 Silence Therapeutics plc Gene Silencing Introduction
        11.8.4 Silence Therapeutics plc Revenue in Gene Silencing Business (2017-2022)
        11.8.5 Silence Therapeutics plc Recent Developments
    11.9 Idera Pharmaceuticals
        11.9.1 Idera Pharmaceuticals Company Details
        11.9.2 Idera Pharmaceuticals Business Overview
        11.9.3 Idera Pharmaceuticals Gene Silencing Introduction
        11.9.4 Idera Pharmaceuticals Revenue in Gene Silencing Business (2017-2022)
        11.9.5 Idera Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Gene Silencing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Transcriptional
    Table 3. Key Players of Post-transcriptional
    Table 4. Key Players of Meiotic
    Table 5. Global Gene Silencing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 6. Global Gene Silencing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Gene Silencing Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Gene Silencing Market Share by Region (2017-2022)
    Table 9. Global Gene Silencing Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Gene Silencing Market Share by Region (2023-2028)
    Table 11. Gene Silencing Market Trends
    Table 12. Gene Silencing Market Drivers
    Table 13. Gene Silencing Market Challenges
    Table 14. Gene Silencing Market Restraints
    Table 15. Global Gene Silencing Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Gene Silencing Revenue Share by Players (2017-2022)
    Table 17. Global Top Gene Silencing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Silencing as of 2021)
    Table 18. Ranking of Global Top Gene Silencing Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Gene Silencing Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Gene Silencing Product Solution and Service
    Table 22. Date of Enter into Gene Silencing Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Gene Silencing Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Gene Silencing Revenue Market Share by Type (2017-2022)
    Table 26. Global Gene Silencing Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Gene Silencing Revenue Market Share by Type (2023-2028)
    Table 28. Global Gene Silencing Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Gene Silencing Revenue Share by Application (2017-2022)
    Table 30. Global Gene Silencing Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Gene Silencing Revenue Share by Application (2023-2028)
    Table 32. North America Gene Silencing Market Size by Type (2017-2022) & (US$ Million)
    Table 33. North America Gene Silencing Market Size by Type (2023-2028) & (US$ Million)
    Table 34. North America Gene Silencing Market Size by Application (2017-2022) & (US$ Million)
    Table 35. North America Gene Silencing Market Size by Application (2023-2028) & (US$ Million)
    Table 36. North America Gene Silencing Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America Gene Silencing Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe Gene Silencing Market Size by Type (2017-2022) & (US$ Million)
    Table 39. Europe Gene Silencing Market Size by Type (2023-2028) & (US$ Million)
    Table 40. Europe Gene Silencing Market Size by Application (2017-2022) & (US$ Million)
    Table 41. Europe Gene Silencing Market Size by Application (2023-2028) & (US$ Million)
    Table 42. Europe Gene Silencing Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Europe Gene Silencing Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Asia Pacific Gene Silencing Market Size by Type (2017-2022) & (US$ Million)
    Table 45. Asia Pacific Gene Silencing Market Size by Type (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Gene Silencing Market Size by Application (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Gene Silencing Market Size by Application (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Gene Silencing Market Size by Region (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Gene Silencing Market Size by Region (2023-2028) & (US$ Million)
    Table 50. Latin America Gene Silencing Market Size by Type (2017-2022) & (US$ Million)
    Table 51. Latin America Gene Silencing Market Size by Type (2023-2028) & (US$ Million)
    Table 52. Latin America Gene Silencing Market Size by Application (2017-2022) & (US$ Million)
    Table 53. Latin America Gene Silencing Market Size by Application (2023-2028) & (US$ Million)
    Table 54. Latin America Gene Silencing Market Size by Country (2017-2022) & (US$ Million)
    Table 55. Latin America Gene Silencing Market Size by Country (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa Gene Silencing Market Size by Type (2017-2022) & (US$ Million)
    Table 57. Middle East and Africa Gene Silencing Market Size by Type (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Gene Silencing Market Size by Application (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Gene Silencing Market Size by Application (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Gene Silencing Market Size by Country (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Gene Silencing Market Size by Country (2023-2028) & (US$ Million)
    Table 62. Alnylam Pharmaceuticals Company Details
    Table 63. Alnylam Pharmaceuticals Business Overview
    Table 64. Alnylam Pharmaceuticals Gene Silencing Product
    Table 65. Alnylam Pharmaceuticals Revenue in Gene Silencing Business (2017-2022) & (US$ Million)
    Table 66. Alnylam Pharmaceuticals Recent Developments
    Table 67. Benitec Biopharma Company Details
    Table 68. Benitec Biopharma Business Overview
    Table 69. Benitec Biopharma Gene Silencing Product
    Table 70. Benitec Biopharma Revenue in Gene Silencing Business (2017-2022) & (US$ Million)
    Table 71. Benitec Biopharma Recent Developments
    Table 72. Arrowhead Pharmaceuticals Company Details
    Table 73. Arrowhead Pharmaceuticals Business Overview
    Table 74. Arrowhead Pharmaceuticals Gene Silencing Product
    Table 75. Arrowhead Pharmaceuticals Revenue in Gene Silencing Business (2017-2022) & (US$ Million)
    Table 76. Arrowhead Pharmaceuticals Recent Developments
    Table 77. Merck Group Company Details
    Table 78. Merck Group Business Overview
    Table 79. Merck Group Gene Silencing Product
    Table 80. Merck Group Revenue in Gene Silencing Business (2017-2022) & (US$ Million)
    Table 81. Merck Group Recent Developments
    Table 82. Eli Lilly (Dicerna Pharmaceuticals) Company Details
    Table 83. Eli Lilly (Dicerna Pharmaceuticals) Business Overview
    Table 84. Eli Lilly (Dicerna Pharmaceuticals) Gene Silencing Product
    Table 85. Eli Lilly (Dicerna Pharmaceuticals) Revenue in Gene Silencing Business (2017-2022) & (US$ Million)
    Table 86. Eli Lilly (Dicerna Pharmaceuticals) Recent Developments
    Table 87. Monsanto (Bayer AG) Company Details
    Table 88. Monsanto (Bayer AG) Business Overview
    Table 89. Monsanto (Bayer AG) Gene Silencing Product
    Table 90. Monsanto (Bayer AG) Revenue in Gene Silencing Business (2017-2022) & (US$ Million)
    Table 91. Monsanto (Bayer AG) Recent Developments
    Table 92. RXi Pharmaceuticals Company Details
    Table 93. RXi Pharmaceuticals Business Overview
    Table 94. RXi Pharmaceuticals Gene Silencing Product
    Table 95. RXi Pharmaceuticals Revenue in Gene Silencing Business (2017-2022) & (US$ Million)
    Table 96. RXi Pharmaceuticals Recent Developments
    Table 97. Silence Therapeutics plc Company Details
    Table 98. Silence Therapeutics plc Business Overview
    Table 99. Silence Therapeutics plc Gene Silencing Product
    Table 100. Silence Therapeutics plc Revenue in Gene Silencing Business (2017-2022) & (US$ Million)
    Table 101. Silence Therapeutics plc Recent Developments
    Table 102. Idera Pharmaceuticals Company Details
    Table 103. Idera Pharmaceuticals Business Overview
    Table 104. Idera Pharmaceuticals Gene Silencing Product
    Table 105. Idera Pharmaceuticals Revenue in Gene Silencing Business (2017-2022) & (US$ Million)
    Table 106. Idera Pharmaceuticals Recent Developments
    Table 107. Research Programs/Design for This Report
    Table 108. Key Data Information from Secondary Sources
    Table 109. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Gene Silencing Market Share by Type: 2021 VS 2028
    Figure 2. Transcriptional Features
    Figure 3. Post-transcriptional Features
    Figure 4. Meiotic Features
    Figure 5. Global Gene Silencing Market Share by Application: 2021 VS 2028
    Figure 6. Cancer Treatment Case Studies
    Figure 7. Neurological Diseases Treatment Case Studies
    Figure 8. Scar Treatment Case Studies
    Figure 9. Other Case Studies
    Figure 10. Gene Silencing Report Years Considered
    Figure 11. Global Gene Silencing Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Gene Silencing Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Gene Silencing Market Share by Region: 2021 VS 2028
    Figure 14. Global Gene Silencing Market Share by Players in 2021
    Figure 15. Global Top Gene Silencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Silencing as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Gene Silencing Revenue in 2021
    Figure 17. North America Gene Silencing Market Size YoY (2017-2028) & (US$ Million)
    Figure 18. North America Gene Silencing Market Size Market Share by Type (2017-2028)
    Figure 19. North America Gene Silencing Market Size Market Share by Application (2017-2028)
    Figure 20. North America Gene Silencing Market Size Share by Country (2017-2028)
    Figure 21. United States Gene Silencing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Gene Silencing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Gene Silencing Market Size YoY (2017-2028) & (US$ Million)
    Figure 24. Europe Gene Silencing Market Size Market Share by Type (2017-2028)
    Figure 25. Europe Gene Silencing Market Size Market Share by Application (2017-2028)
    Figure 26. Europe Gene Silencing Market Size Share by Country (2017-2028)
    Figure 27. Germany Gene Silencing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. France Gene Silencing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. U.K. Gene Silencing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Italy Gene Silencing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Russia Gene Silencing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Nordic Countries Gene Silencing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Gene Silencing Market Size YoY (2017-2028) & (US$ Million)
    Figure 34. Asia Pacific Gene Silencing Market Size Market Share by Type (2017-2028)
    Figure 35. Asia Pacific Gene Silencing Market Size Market Share by Application (2017-2028)
    Figure 36. Asia Pacific Gene Silencing Market Size Share by Region (2017-2028)
    Figure 37. China Gene Silencing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Japan Gene Silencing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. South Korea Gene Silencing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Southeast Asia Gene Silencing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. India Gene Silencing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Australia Gene Silencing Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 43. Latin America Gene Silencing Market Size YoY (2017-2028) & (US$ Million)
    Figure 44. Latin America Gene Silencing Market Size Market Share by Type (2017-2028)
    Figure 45. Latin America Gene Silencing Market Size Market Share by Application (2017-2028)
    Figure 46. Latin America Gene Silencing Market Size Share by Country (2017-2028)
    Figure 47. Mexico Gene Silencing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Brazil Gene Silencing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Gene Silencing Market Size YoY (2017-2028) & (US$ Million)
    Figure 50. Middle East and Africa Gene Silencing Market Size Market Share by Type (2017-2028)
    Figure 51. Middle East and Africa Gene Silencing Market Size Market Share by Application (2017-2028)
    Figure 52. Middle East and Africa Gene Silencing Market Size Share by Country (2017-2028)
    Figure 53. Turkey Gene Silencing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Gene Silencing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. UAE Gene Silencing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. Alnylam Pharmaceuticals Revenue Growth Rate in Gene Silencing Business (2017-2022)
    Figure 57. Benitec Biopharma Revenue Growth Rate in Gene Silencing Business (2017-2022)
    Figure 58. Arrowhead Pharmaceuticals Revenue Growth Rate in Gene Silencing Business (2017-2022)
    Figure 59. Merck Group Revenue Growth Rate in Gene Silencing Business (2017-2022)
    Figure 60. Eli Lilly (Dicerna Pharmaceuticals) Revenue Growth Rate in Gene Silencing Business (2017-2022)
    Figure 61. Monsanto (Bayer AG) Revenue Growth Rate in Gene Silencing Business (2017-2022)
    Figure 62. RXi Pharmaceuticals Revenue Growth Rate in Gene Silencing Business (2017-2022)
    Figure 63. Silence Therapeutics plc Revenue Growth Rate in Gene Silencing Business (2017-2022)
    Figure 64. Idera Pharmaceuticals Revenue Growth Rate in Gene Silencing Business (2017-2022)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed